lecanemab
Experimental Drug Appears to Slow Down Alzheimer’s Disease
2022-11-30 16:51:08
by
TWN Staff
An experimental drug that removes a substance called amyloid — a toxic protein — from the brain appears to slow down Alzheimer's disease. The drug, lecanemab, reduced the rate of cognitive decline by 27% in a study of nearly 1,800... Read More
Straight From The Well
